- Home
- LXRX vs VINP Comparison
LXRX vs VINP Comparison
Compare LXRX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | VINP |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 638.8M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LXRX | VINP |
|---|---|---|
| Price | $2.35 | $9.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.15 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 4.5M | 50.1K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | $18.07 |
| Revenue Next Year | N/A | $12.74 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.00 | $9.29 |
| 52 Week High | $2.68 | $13.61 |
Technical Indicators
Market Signals| Indicator | LXRX | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 43.34 |
| Support Level | $1.52 | $9.52 |
| Resistance Level | $2.53 | $10.28 |
| Average True Range (ATR) | 0.13 | 0.32 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 76.25 | 16.50 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.